68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-grazytracer in subjects with non-small cell lung cancer, melanoma or lymphoma receiving immunotherapy.
Epistemonikos ID: fc98a54232e0c2cef2aa1c9dfc3a73898d0bcf0b
First added on: May 09, 2024